These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2992533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T, Kase N, Kita H, Uematsu T.
    Arzneimittelforschung; 1986 Nov; 36(1):29-34. PubMed ID: 3754142
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y, Iwama T, Yamashita T, Sakai T, Hibi M, Tanaka S, Shigenobu K, Kasuya Y.
    Arch Int Pharmacodyn Ther; 1991 Nov; 314():57-73. PubMed ID: 1668604
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dependence of Ca outflow and depression of frog myocardium contraction on ryodipine concentration.
    Narusevicius E, Gendviliene V, Macianskiene R, Hmelj-Dunai G, Velena A, Duburs G.
    Gen Physiol Biophys; 1988 Feb; 7(1):51-7. PubMed ID: 3396849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D.
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of slow calcium channel blockers on the electromechanical activity of frog myocardium in the presence of epinephrine.
    Gendviliené V, Macianskiené R, Narusevicius E, Jurevicius J, Velena A, Duburs G.
    Gen Physiol Biophys; 1985 Aug; 4(4):349-58. PubMed ID: 4029601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.
    Ninomiya M, Tani T, Nakajima S, Ueda M.
    Jpn J Pharmacol; 1989 Oct; 51(2):227-38. PubMed ID: 2593380
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.